The short variant of the polymorphism within the promoter region of the serotonin transporter gene is a risk factor for late onset Alzheimer's disease

Molecular Psychiatry

Volumn 3, Issue 5, 1998, Pages 438-441

  Oliveira, Jrm ^a   Gallindo, R M ^c   Maia, Lgs ^a   Brito Marques, P R ^a   Otto, P A ^b   Passos Bueno, M R ^a   Morais, M A ^b  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

5 HTT serotonin polymorphism; Allelic association; Late onset Alzheimer's disease

Indexed keywords

SEROTONIN TRANSPORTER;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DELETION; GENE FREQUENCY; GENE INSERTION; HUMAN; MAJOR CLINICAL STUDY; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; STATISTICAL ANALYSIS;

EID: 0031663853     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000417     Document Type: Article

References (34)

1. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
2. Sherrington R, Rogaev El, Liang Y, Rogaeva EA, Levesque G, Ikeda M et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1995; 375: 754-760.
3. Levy-Lahad E, Wijsman EM, Nemens E, Anderson L, Goddard KAB, Weber JL ef aJ. A familial Alzheimer's disease locus on chromosome 1. Science 1995; 2G9: 970-973.
4. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingel WH et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 260: 973-977.
5. Strittmatter WJ, Saunders AM, Schemechel D, Pericak-Vance M, Enghild J, Salvesn GS et al. Apolipoprotein E: high avidity binding
6. to ß-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease. Proc Nail Acad Sei USA 1Q93; 190: 1977-1081.
7. Oliveira JRM, Shimokomaki CM, Brito-Marques PR, Okuma M, Passes-Bueno MR, Zatz M et al. The use of apolipoprotein E genotype for preclinical detection of risk's group for Alzheimer's disease. Am ] Med Genet (Neuropsychiatrie Genetics) 1997; 74: 216-217.
8. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PO, Scott WK, Terwedow HA et al. Complete genomic screen in late-onset familial Alzheimer disease: evidence for a new locus on chromosome 12. MAM 1997; 278: 15: 1237-1241.
9. Meltzer H, Arora R, Baber R, Tricou B. Serotonin uptake in blood platelets of psychiatric patients. Arch Gen Psychiatry 1981; 38: 1322-1329.
10. Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems in depression. / Clin Psychiatry 1992; 53 (Suppl): 3-7.
11. Sthal S, Woo D, Mefford I, Berger P, Ciaranello R. Hyperserotonemia and platelet serotonin uptake in schizophrenia and affective disorders. Am }Psychiatry 1983; 140: 26-31.
12. Joyce JN, Shame A, Lexow N, Winokur A, Casanova MF, Kleinman JE. Serotonin uptake sites and serotonin receptors are altered in the limbic system of schizophrenics. Neuropsychopharmacology 1993; 8: 315-336.
13. Losch KP, Gross J, Franzek E, Wolozi BL, Rieder P, Murphy DL. Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biol Psychiatry 1995; 37: 215-223.
14. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D e( al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry 1990; 1: 453-460.
15. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P. Isolation of a cDNA encoding the human brain serotonin transporter. / Neural Transm 1993; 91: 67-73.
16. Lesch KP, Balling U, Gross J, Strauss K, Murphy DL, Riederer P. Organization of the human serotonin transporter gene. / Neural Transm (Genet Sect) 1994; 95: 157-162.
17. Ramamoorthy S, Bauman A, Moore K, Han H, Yang-Feng L, Chang A et al. Regulation of the human serotonin transporter: antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc NatlAcad Sei 1993; 90: 2542-2546.
18. Gelernter J, Pakstis AJ, Kidd KK. Linkage mapping of the serotonin transporter protein gene SCL 6A4 on chromosome 17. Human Genet 1995; 96: 677-680.
19. Heils A, Teufel A, Petri S, Seeman M, Bengel D, Balling U et al. Functional promoter and polyadenylation site mapping of the human serotonin (5-HT) transporter gene. / Neural Transm(Gen Sect) 1995; 102: 247-254.
20. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; GG: 2621-2624.
21. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Pétri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
22. Oliveira JRM, Otto PA, Vallada HP, Lauriano V, Elkis H, Lafer B et al. Analysis of a novel functional polymorphism within the promoter region of the serotonin transporter gene (5-HTT) in Brazilian patients affected by bipolar disorder and schizophrenia. Am J Med Genet (Neuropsychiatrie Genetics) 1998; (in press).
23. Stober G, Jatzke S, Heils A, Jungkunz G, Funchs E, Knapp M et al. Susceptibility for schizophrenia is not influenced by a functional insertion/deletion variant in the promoter of the serotonin transporter gene. Eur Arch Psychiat Clin Neurosci 1997; (in press).
24. Klauck SM, Poustka F, Benner A, Lesch KP, Poustka A. Serotonin transporter (5-HTT) gene variants associated with autism? Hum Molec Genet 1997; G: 2233-2238.
25. Li T, Holmes C, Sham PC, Vallada HP, Birkett J, Kirov G étal. Allelic functional variation of serotonin transporter expression is a susceptibility factor for late onset Alzheimer's disease. Neuroreport 1997; 8: 683-686.
26. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA \vork group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology 1984; 34: 939-944.
27. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. / Psychiatry Res 1975; 12: 189-198.
28. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 1968; 114: 797-811.
29. Haberman SJ. The analysis of residuals in cross-classified tables. Biometrics 1973; 23: 205-220.
30. Deckert J, Catalano M, Heils A, Di Bella D, Friess F, Politi E et al. Functional promoter polymorphism of the human serotonin trans-porter: lack of association with panic diorder. Psychiatric Genet 1997; 7: 45-17.
31. Billet EA, Richter MA, King N, Heils A, Losch KP, Kennedy JL. Obsessive compulsive disorder, response to serotonin reuptake inhibitors and the serotonin transporter gene. Mol Psychiatry 19972: 403-406.
32. Feinberg T, Goodman B. Affective illness, dementia, and pseudodementia. 1 Clin Psychiatry 1984; 3: 99-103.
33. Everitt BS. The Analysis of Contingency Tables. Chapman & Hall: London, 1977.
34. Correspondence: M Zatz, Department of Biology, Institute of Biosciences, University of Säo Paulo, CEP 05508-900, SP, Brazil. E-mail: mayazatz@usp.br